Agency Information Collection Activities: Submission for OMB Review; Comment Request, 1446-1448 [2011-209]
Download as PDF
srobinson on DSKHWCL6B1PROD with NOTICES
1446
Federal Register / Vol. 76, No. 6 / Monday, January 10, 2011 / Notices
Date: February 7–8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Guest Suites Hotel at
Doheny Beach, 34402 Pacific Coast Highway,
Dana Point, CA 92629.
Contact Person: Behrouz Shabestari, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7854, Bethesda, MD 20892. (301) 435–
2409. shabestb@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Bioengineering,
Technology and Surgical Sciences Study
Section.
Date: February 7–8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Khalid Masood, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5120,
MSC 7854, Bethesda, MD 20892. 301–435–
2392. masoodk@csr.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group, Aging Systems and Geriatrics Study
Section.
Date: February 7–8, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel, 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Person: James P. Harwood, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5168,
MSC 7840, Bethesda, MD 20892. 301–435–
1256. harwoodj@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Clinical Molecular
Imaging and Probe Development.
Date: February 7–8, 2011.
Agenda: 2 p.m. to 12 p.m.
Place: To review and evaluate grant
applications.
Contact Person: Doubletree Guest Suites
Hotel at Doheny Beach, 34402 Pacific Coast
Highway, Dana Point, CA 92629. Eileen W.
Bradley, DSC, Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 5100, MSC 7854, Bethesda, MD 20892.
(301) 435–1179. bradleye@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Review of
NCRR Resource Southwestern NMR Center
for In Vivo Metabolism.
Date: February 7–9, 2011.
Time: 6 p.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Dallas Market
Center, 2325 North Stemmons Freeway,
Dallas, TX 75207.
VerDate Mar<15>2010
18:19 Jan 07, 2011
Jkt 223001
Contact Person: Antonio Sastre, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5215,
MSC 7412, Bethesda, MD 20892. 301–435–
2592. sastrea@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Progra.m. Nos. 93.306, Comparative
Medicine; 93.333, Clinical Research, 93.306,
93.333, 93.337, 93.393–93.396, 93.837–
93.844, 93.846–93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 4, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–257 Filed 1–7–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, January
10, 2011, 8 a.m. to January 11, 2011, 5
p.m., National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
which was published in the Federal
Register on December 22, 2010, 75 FR
80508.
The starting time of the meeting on
January 10, 2011 has been changed to 11
a.m. until adjournment on January 11,
2011. The meeting is closed to the
public.
Dated: January 4, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–255 Filed 1–7–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
F—Manpower & Training. To review and
evaluate grant applications.
Date: February 22–23, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Old Town, 1767
King Street, Alexandria, VA 22314.
Contact Person: Lynn M. Amende, PhD,
Scientific Review Officer, Resources And
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd., Room
8105, Bethesda, MD 20892, 301–451–4759,
amendel@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: January 4, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–253 Filed 1–7–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Program Evaluation for
Assertive Adolescent & Family
Treatment (AAFT) Program—NEW
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA), Center for Substance Abuse
Services (CSAT) has implemented the
Assertive Adolescent and Family
Treatment (AAFT) program to promote
the adoption of evidence-based
practices by community providers in the
E:\FR\FM\10JAN1.SGM
10JAN1
1447
Federal Register / Vol. 76, No. 6 / Monday, January 10, 2011 / Notices
area of adolescent substance use
treatment. The AAFT program provides
evidence-based substance use services
to adolescents and their families, as well
as to transition-age youth (TAY),
caregivers, and their families/mentors.
This program is based on evidence that
families/caregivers and other
appropriate adults are an integral part of
the treatment process and their
inclusion in services increases the
likelihood of successful treatment and
reintegration of adolescents/TAYs into
their communities following treatment.
AAFT requires grantees to implement
the Adolescent Community
Reinforcement Approach (A–CRA)
coupled with Assertive Continuing Care
(ACC) to provide treatment that is
context-specific, family-centered, and
community-based. Grantees are also
required to use the Global Appraisal of
Individual Needs (GAIN) as the
common assessment instrument across
programs to improve intake assessment,
clinical interpretation, monitoring, and
data management. The GAIN is used for
diagnosis and to assist in placement,
treatment planning, local evaluation,
and continuous quality improvement for
programs. In supporting AAFT and to
ensure that each implementation
activity required by AAFT is
implemented well and as faithfully as
possible by grantees, CSAT has
provided, through Chestnut Health
Systems, a well-thought-out package of
implementation supports, including
manual-assisted training in and
certification for clinical staff on A–CRA
and ACC, training/certification in GAIN,
monitoring/coaching/mentoring/support
for clinicians and supervisors,
implementation calls and monthly
progress reports, and topical
workgroups that share ideas and
resources among grantees. The
overarching objective of the multi-site,
Assertive Adolescent and Family
Treatment (AAFT) process and outcome
evaluation is to assess and document
the process of implementation in the
2009 cohort of AAFT grantees and to
explore the role that implementation
supports play in how well these
programs evolve.
CSAT is requesting approval from the
Office of Management and Budget
(OMB) to implement a data collection
document, the Annual Program Survey,
to gather longitudinal data (end of each
of 3 project years) from a range of
grantee personnel to evaluate the
implementation, expansion, and
sustainability of adolescent substance
use services developed under the AAFT
program.
The current proposal requests
implementing the Annual Program
Survey to collect information in the
following areas:
a. Attitudes toward evidence-based
practices generally, and AAFT model
components in particular (e.g., attitudes
toward using a treatment manual,
achieving certification);
b. Grantee involvement with the
implementation supports provided by
Chestnut Health Systems and their
reactions to those implementation
supports;
c. Perceived changes in clinical
practice/behavior indicating movement
toward full A–CRA/ACC
implementation;
d. Perceived barriers encountered in
implementation and compensatory
strategies;
e. Report on project progress,
including activities related to the AAFT
program, changes to program plans,
project accomplishments, and efforts to
plan for sustainability of the program.
This information would be collected
annually—in October/November of each
project year. The survey has three
versions tailored to address the
respondents’ roles in the grant
(Principal Investigator/Program
Director, Clinical Supervisor/Clinician,
and Evaluator/Data Manager). Staffing
patterns at each grantee site vary greatly;
therefore, CSAT is only able to estimate
the total number of respondents for each
category based on initial grantee
proposals. CSAT expects to conduct
surveys with approximately 21
administrators, 56 clinical staff, and 28
evaluators/data managers. The total
number of respondents—105
individuals—represent project staff at
three distinct levels across 14 grantee
sites.
The burden estimate for completing
the Annual Program Survey is as
follows:
ANNUAL REPORTING BURDEN—SUMMARY TABLE
Data
collection
activity
Number
of
respondents 1
Responses
per
respondent 2
Average
hours per
response
Total
responses
Total
hour
burden
Wage rate
(hourly)
Total hour cost
($)
CY 2010–12 ANNUAL REPORTING BURDEN
AAFT Implementation
Survey—Principal Investigator/Program
Director .....................
AAFT Implementation
Survey—Clinical Supervisor/Clinician ......
AAFT Implementation
Survey—Evaluator/
Data Manager ...........
Annual Total ..........
21
1
21
0.75
15.75
50
787.50
56
1
56
0.75
42
26
1,092.00
28
1
28
0.75
21
15
315.00
105
........................
105
........................
........................
2,194.50
78.75
srobinson on DSKHWCL6B1PROD with NOTICES
1 Represents
project staff at three distinct levels—administrators, clinical staff, evaluators—across 14 grantee sites. Number of respondents is
an average of respondents per role based on staffing patterns described in grantee proposals.
2 The AAFT Implementation Survey will be completed once by respondents at all 14 sites at the end of each project year.
Written comments and
recommendations concerning the
proposed information collection should
be sent by February 9, 2011 to:
SAMHSA Desk Officer, Human
Resources and Housing Branch, Office
VerDate Mar<15>2010
18:19 Jan 07, 2011
Jkt 223001
of Management and Budget, New
Executive Office Building, Room 10235,
Washington, DC 20503; due to potential
delays in OMB’s receipt and processing
of mail sent through the U.S. Postal
Service, respondents are encouraged to
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
submit comments by fax to: 202–395–
5806.
E:\FR\FM\10JAN1.SGM
10JAN1
1448
Federal Register / Vol. 76, No. 6 / Monday, January 10, 2011 / Notices
Dated: January 3, 2011.
Elaine Parry,
Director, Office of Management, Technology
and Operations.
[FR Doc. 2011–209 Filed 1–7–11; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2009–0973]
Random Drug Testing Rate for
Covered Crewmembers
Coast Guard, DHS.
Notice of minimum random
drug testing rate.
AGENCY:
ACTION:
The Coast Guard has set the
calendar year 2011 minimum random
drug testing rate at 50 percent of
covered crewmembers.
DATES: The minimum random drug
testing rate is effective January 1, 2011
through December 31, 2011. Marine
employers must submit their 2010
Management Information System (MIS)
reports no later than March 15, 2011.
ADDRESSES: Annual MIS reports may be
submitted to Commandant (CG–545),
U.S. Coast Guard Headquarters, 2100
Second Street, SW., STOP 7561,
Washington, DC 20593–7581 or by
electronic submission to the following
Internet address: https://
homeport.uscg.mil/Drugtestreports.
FOR FURTHER INFORMATION CONTACT: For
questions about this notice, please
contact Mr. Robert C. Schoening, Drug
and Alcohol Program Manager, Office of
Investigations and Casualty Analysis
(CG–545), U.S. Coast Guard
Headquarters, telephone 202–372–1033.
If you have questions on viewing or
submitting material to the docket, call
Renee V. Wright, Program Manager,
Docket Operations, telephone 202–366–
9826.
SUPPLEMENTARY INFORMATION: Under 46
CFR 16.230, the Coast Guard requires
marine employers to establish random
drug testing programs for covered
crewmembers on inspected and
uninspected vessels.
Every marine employer is required by
46 CFR 16.500 to collect and maintain
a record of drug testing program data for
each calendar year, and submit this data
by 15 March of the following year to the
Coast Guard in an annual MIS report.
Marine employers may either submit
their own MIS reports or have a
consortium or other employer
representative submit the data in a
consolidated MIS report.
srobinson on DSKHWCL6B1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
18:19 Jan 07, 2011
Jkt 223001
The purpose of setting a minimum
random drug testing rate is to assist the
Coast Guard in analyzing its current
approach for deterring and detecting
illegal drug abuse in the maritime
industry. The testing rate for calendar
year 2010 was 50 percent.
The Coast Guard may lower this rate
if, for two consecutive years, the drug
test positive rate is less than 1.0 percent,
in accordance with 46 CFR 16.230(f)(2).
Since 2009 MIS data indicates that the
positive rate is greater than one percent
industry-wide (1.03 percent), the Coast
Guard announces that the minimum
random drug testing rate will continue
at 50 percent of covered employees for
the period of January 1, 2011 through
December 31, 2011 in accordance with
46 CFR 16.230(e).
Each year, the Coast Guard will
publish a notice reporting the results of
random drug testing for the previous
calendar year’s MIS data and the
minimum annual percentage rate for
random drug testing for the next
calendar year.
Dated: December 23, 2010.
Kevin S. Cook,
Rear Admiral, U.S. Coast Guard, Director of
Prevention Policy.
[FR Doc. 2011–170 Filed 1–7–11; 8:45 am]
BILLING CODE 9110–04–P
The survey also provides estimates of
the characteristics of apartments being
absorbed, and provides a basis for
analyzing the degree to which
apartment-building activity is meeting
the present and future needs of the
public. Data are collected under Title
12, U.S.C. Sec. 1701Z–1 and 2.
DATES:
Comments Due Date: February 9,
2011.
Interested persons are
invited to submit comments regarding
this proposal. Comments should refer to
the proposal by name and/or OMB
approval Number (2528–0013) and
should be sent to: HUD Desk Officer,
Office of Management and Budget, New
Executive Office Building, Washington,
DC 20503; fax: 202–395–5806. E-mail:
OIRA_Submission@omb.eop.gov.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
Colette Pollard, Reports Management
Officer, QDAM, Department of Housing
and Urban Development, 451 Seventh
Street, SW., Washington, DC 20410; email Colette Pollard at
Colette.Pollard@hud.gov or telephone
(202) 402–3400. This is not a toll-free
number. Copies of available documents
submitted to OMB may be obtained
from Ms. Pollard.
This
notice informs the public that the
Department of Housing and Urban
Development has submitted to OMB a
request for approval of the Information
collection described below. This notice
is soliciting comments from members of
the public and affecting agencies
concerning the proposed collection of
information to: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information; (3) Enhance the quality,
utility, and clarity of the information to
be collected; and (4) Minimize the
burden of the collection of information
on those who are to respond; including
through the use of appropriate
automated collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
This notice also lists the following
information:
Title of Proposal: Survey of Market
Absorption of New Multifamily Units.
OMB Approval Number: 2528–0013.
Form Numbers: H–31.
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5480–N–01]
Notice of Submission of Proposed
Information Collection to OMB Survey
of Market Absorption of New
Multifamily Units
Office of the Chief Information
Officer, HUD.
ACTION: Notice.
AGENCY:
The proposed information
collection requirement described below
has been submitted to the Office of
Management and Budget (OMB) for
review, as required by the Paperwork
Reduction Act. The Department is
soliciting public comments on the
subject proposal.
This survey provides the data
necessary to measure the rate at which
different types of new rental apartments
and new condominium apartments are
absorbed, that is, taken off the market,
usually by being rented or sold, over the
course of the first twelve months
following completion of a building. The
data is collected at quarterly intervals
until the twelve months expire or until
the units in a building are completely
absorbed.
SUMMARY:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
E:\FR\FM\10JAN1.SGM
10JAN1
Agencies
[Federal Register Volume 76, Number 6 (Monday, January 10, 2011)]
[Notices]
[Pages 1446-1448]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-209]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under OMB review, in compliance with the Paperwork
Reduction Act (44 U.S.C. Chapter 35). To request a copy of these
documents, call the SAMHSA Reports Clearance Officer on (240) 276-1243.
Project: Program Evaluation for Assertive Adolescent & Family Treatment
(AAFT) Program--NEW
The Substance Abuse and Mental Health Services Administration's
(SAMHSA), Center for Substance Abuse Services (CSAT) has implemented
the Assertive Adolescent and Family Treatment (AAFT) program to promote
the adoption of evidence-based practices by community providers in the
[[Page 1447]]
area of adolescent substance use treatment. The AAFT program provides
evidence-based substance use services to adolescents and their
families, as well as to transition-age youth (TAY), caregivers, and
their families/mentors. This program is based on evidence that
families/caregivers and other appropriate adults are an integral part
of the treatment process and their inclusion in services increases the
likelihood of successful treatment and reintegration of adolescents/
TAYs into their communities following treatment. AAFT requires grantees
to implement the Adolescent Community Reinforcement Approach (A-CRA)
coupled with Assertive Continuing Care (ACC) to provide treatment that
is context-specific, family-centered, and community-based. Grantees are
also required to use the Global Appraisal of Individual Needs (GAIN) as
the common assessment instrument across programs to improve intake
assessment, clinical interpretation, monitoring, and data management.
The GAIN is used for diagnosis and to assist in placement, treatment
planning, local evaluation, and continuous quality improvement for
programs. In supporting AAFT and to ensure that each implementation
activity required by AAFT is implemented well and as faithfully as
possible by grantees, CSAT has provided, through Chestnut Health
Systems, a well-thought-out package of implementation supports,
including manual-assisted training in and certification for clinical
staff on A-CRA and ACC, training/certification in GAIN, monitoring/
coaching/mentoring/support for clinicians and supervisors,
implementation calls and monthly progress reports, and topical
workgroups that share ideas and resources among grantees. The
overarching objective of the multi-site, Assertive Adolescent and
Family Treatment (AAFT) process and outcome evaluation is to assess and
document the process of implementation in the 2009 cohort of AAFT
grantees and to explore the role that implementation supports play in
how well these programs evolve.
CSAT is requesting approval from the Office of Management and
Budget (OMB) to implement a data collection document, the Annual
Program Survey, to gather longitudinal data (end of each of 3 project
years) from a range of grantee personnel to evaluate the
implementation, expansion, and sustainability of adolescent substance
use services developed under the AAFT program.
The current proposal requests implementing the Annual Program
Survey to collect information in the following areas:
a. Attitudes toward evidence-based practices generally, and AAFT
model components in particular (e.g., attitudes toward using a
treatment manual, achieving certification);
b. Grantee involvement with the implementation supports provided by
Chestnut Health Systems and their reactions to those implementation
supports;
c. Perceived changes in clinical practice/behavior indicating
movement toward full A-CRA/ACC implementation;
d. Perceived barriers encountered in implementation and
compensatory strategies;
e. Report on project progress, including activities related to the
AAFT program, changes to program plans, project accomplishments, and
efforts to plan for sustainability of the program.
This information would be collected annually--in October/November
of each project year. The survey has three versions tailored to address
the respondents' roles in the grant (Principal Investigator/Program
Director, Clinical Supervisor/Clinician, and Evaluator/Data Manager).
Staffing patterns at each grantee site vary greatly; therefore, CSAT is
only able to estimate the total number of respondents for each category
based on initial grantee proposals. CSAT expects to conduct surveys
with approximately 21 administrators, 56 clinical staff, and 28
evaluators/data managers. The total number of respondents--105
individuals--represent project staff at three distinct levels across 14
grantee sites.
The burden estimate for completing the Annual Program Survey is as
follows:
Annual Reporting Burden--Summary Table
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Data collection activity respondents Responses per Total Average hours Total hour Wage rate Total hour
\1\ respondent \2\ responses per response burden (hourly) cost ($)
--------------------------------------------------------------------------------------------------------------------------------------------------------
CY 2010-12 Annual Reporting Burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
AAFT Implementation Survey--Principal 21 1 21 0.75 15.75 50 787.50
Investigator/Program Director............
AAFT Implementation Survey--Clinical 56 1 56 0.75 42 26 1,092.00
Supervisor/Clinician.....................
AAFT Implementation Survey--Evaluator/Data 28 1 28 0.75 21 15 315.00
Manager..................................
-------------------------------------------------------------------------------------------------------------
Annual Total.......................... 105 .............. 105 .............. 78.75 .............. 2,194.50
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ Represents project staff at three distinct levels--administrators, clinical staff, evaluators--across 14 grantee sites. Number of respondents is an
average of respondents per role based on staffing patterns described in grantee proposals.
\2\ The AAFT Implementation Survey will be completed once by respondents at all 14 sites at the end of each project year.
Written comments and recommendations concerning the proposed
information collection should be sent by February 9, 2011 to: SAMHSA
Desk Officer, Human Resources and Housing Branch, Office of Management
and Budget, New Executive Office Building, Room 10235, Washington, DC
20503; due to potential delays in OMB's receipt and processing of mail
sent through the U.S. Postal Service, respondents are encouraged to
submit comments by fax to: 202-395-5806.
[[Page 1448]]
Dated: January 3, 2011.
Elaine Parry,
Director, Office of Management, Technology and Operations.
[FR Doc. 2011-209 Filed 1-7-11; 8:45 am]
BILLING CODE 4162-20-P